my account  log out
 

Afuco™ Anti-Human HLA-DR βchain ADCC Theraputic Antibody (1D09C3), ADCC Enhanced

Create: 08/09/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:Anti-HLA-DR βchain ADCC Enhanced Antibody (1D09C3) is an ADCC enhanced antibody produced by our Afuco™ platform. 1D09C3 is a human monoclonal IgG4-type antibody against human leukocyte antigen-DR (HLA-DR) which has demonstrated pro-apoptotic activity against lymphoid tumors in vitro and in vivo. 1D09C3 could be administered safely in patients with advanced B cell malignancies. https://www.creativebiolabs.net/Anti-HLA-DR-%CE%B2chain-ADCC-Enhanced-Antibody-1D09C3-20652.htm
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer214
Feb 01 2023 GVBE Buffer214
Feb 01 2023 GVB++ (with Ca and Mg) Buffer221
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)208
Aug 30 2019Anti-HSV-2 gH Antibody392
Aug 30 2019Anti-L. major LPG Antibody476
Aug 30 2019Anti-DENV-1 Antibody385
Aug 30 2019Anti-BPV-1 L1 Antibody400
Aug 30 2019Anti-H3N2 HA Antibody387
Aug 30 2019Anti-EIAV env Antibody411

return back

Copyright © toextrade Inc. All rights reserved. Contact us